32 results
424B4
PCSA
Processa Pharmaceuticals Inc
29 Jan 24
Prospectus supplement with pricing info
4:15pm
the compensation of our named executive officers.
Elements of Executive Compensation
We believe the most effective compensation package for our named executive
8-K
EX-10.1
215pd
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
8-K
EX-1.1
qlmzxo3
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm
424B4
4y4ysi72zxk
5 Oct 20
Prospectus supplement with pricing info
4:16pm